Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Patient outcomes from 10 years of annual diabetes reviews in New Zealand.

Tomlin AM, Dovey SM, Tilyard MW.

Diabetes Res Clin Pract. 2013 Nov;102(2):129-37. doi: 10.1016/j.diabres.2013.09.002. Epub 2013 Sep 14.

PMID:
24149065
[PubMed - indexed for MEDLINE]
2.

Health outcomes for diabetes patients returning for three annual general practice checks.

Tomlin A, Dovey S, Tilyard M.

N Z Med J. 2007 Apr 13;120(1252):U2493.

PMID:
17460743
[PubMed - indexed for MEDLINE]
3.

Trends in the management of risk of diabetes complications in different ethnic groups in New Zealand primary care.

Agban H, Elley CR, Kenealy T, Robinson E.

Prim Care Diabetes. 2008 Dec;2(4):181-6. doi: 10.1016/j.pcd.2008.08.002. Epub 2008 Sep 30.

PMID:
18829410
[PubMed - indexed for MEDLINE]
4.

Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.

Plosker GL, Figgitt DP.

Pharmacoeconomics. 2004;22(6):389-411. Review.

PMID:
15099124
[PubMed - indexed for MEDLINE]
5.

Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation.

Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S.

Health Technol Assess. 2010 Jul;14(36):1-248. doi: 10.3310/hta14360. Review.

PMID:
20646668
[PubMed - indexed for MEDLINE]
Free Article
6.

[Prevalence of diabetes, antidiabetic treatment and chronic diabetic complications reported by general practitioners].

Fabian W, Majkowska L, Stefański A, Moleda P.

Przegl Lek. 2005;62(4):201-5. Polish.

PMID:
16229234
[PubMed - indexed for MEDLINE]
7.

Switching from premixed insulin to glargine-based insulin regimen improves glycaemic control in patients with type 1 or type 2 diabetes: a retrospective primary-care-based analysis.

Sharplin P, Gordon J, Peters JR, Tetlow AP, Longman AJ, McEwan P.

Cardiovasc Diabetol. 2009 Feb 16;8:9. doi: 10.1186/1475-2840-8-9.

PMID:
19220880
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

[Prevalence, drug treatment and metabolic control of diabetes mellitus in primary care].

Pittrow D, Stalla GK, Zeiher AM, Silber S, März W, Pieper L, Klotsche J, Glaesmer H, Ruf G, Schneider HJ, Lehnert H, Böhler S, Koch U, Wittchen HU.

Med Klin (Munich). 2006 Aug 15;101(8):635-44. German.

PMID:
16896570
[PubMed - indexed for MEDLINE]
9.

Optimization of insulin therapy in patients with type 2 diabetes mellitus: beyond basal insulin.

Blak BT, Smith HT, Hards M, Curtis BH, Ivanyi T.

Diabet Med. 2012 Jul;29(7):e13-20. doi: 10.1111/j.1464-5491.2012.03586.x.

PMID:
22268988
[PubMed - indexed for MEDLINE]
10.

[Optimised glycaemic control and dose titration with insulin glargine (Lantus) by general practitioners in Switzerland: results of the OPTI-LAN Postmarketing Study].

Spirk D, Lareida J, Scheidegger K, Diem P.

Praxis (Bern 1994). 2009 Mar 18;98(6):315-20. doi: 10.1024/1661-8157.98.6.315. German.

PMID:
19291638
[PubMed - indexed for MEDLINE]
11.

Diabetes in children and young adults in Waikato Province, New Zealand: outcomes of care.

Scott A, Whitcombe S, Bouchier D, Dunn P.

N Z Med J. 2004 Dec 17;117(1207):U1219.

PMID:
15608812
[PubMed - indexed for MEDLINE]
12.

Meeting American Diabetes Association guidelines in endocrinologist practice.

Miller CD, Phillips LS, Tate MK, Porwoll JM, Rossman SD, Cronmiller N, Gebhart SS.

Diabetes Care. 2000 Apr;23(4):444-8.

PMID:
10857932
[PubMed - indexed for MEDLINE]
Free Article
13.

Can primary care team-based transition to insulin improve outcomes in adults with type 2 diabetes: the stepping up to insulin cluster randomized controlled trial protocol.

Furler JS, Young D, Best J, Patterson E, O'Neal D, Liew D, Speight J, Segal L, May C, Manski-Nankervis JA, Holmes-Truscott E, Ginnivan L, Blackberry ID.

Implement Sci. 2014 Feb 14;9:20. doi: 10.1186/1748-5908-9-20.

PMID:
24528528
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Evaluation of diabetes care in the Otago region using a diabetes register, 1998-2003.

Coppell KJ, Anderson K, Williams S, Manning P, Mann J.

Diabetes Res Clin Pract. 2006 Mar;71(3):345-52. Epub 2005 Sep 23.

PMID:
16183162
[PubMed - indexed for MEDLINE]
15.

Insulin therapy in type 2 diabetes patients failing oral agents: cost-effectiveness of biphasic insulin aspart 70/30 vs. insulin glargine in the US.

Ray JA, Valentine WJ, Roze S, Nicklasson L, Cobden D, Raskin P, Garber A, Palmer AJ.

Diabetes Obes Metab. 2007 Jan;9(1):103-13.

PMID:
17199725
[PubMed - indexed for MEDLINE]
16.
17.
18.

Hospital admissions in diabetic and non-diabetic patients: a case-control study.

Tomlin AM, Tilyard MW, Dovey SM, Dawson AG.

Diabetes Res Clin Pract. 2006 Sep;73(3):260-7. Epub 2006 Feb 28.

PMID:
16504336
[PubMed - indexed for MEDLINE]
19.

Long-term outcome of insulin pump therapy in children with type 1 diabetes assessed in a large population-based case-control study.

Johnson SR, Cooper MN, Jones TW, Davis EA.

Diabetologia. 2013 Nov;56(11):2392-400. doi: 10.1007/s00125-013-3007-9. Epub 2013 Aug 21.

PMID:
23963323
[PubMed - indexed for MEDLINE]
20.

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study.

Blonde L, Merilainen M, Karwe V, Raskin P; TITRATE Study Group.

Diabetes Obes Metab. 2009 Jun;11(6):623-31. doi: 10.1111/j.1463-1326.2009.01060.x.

PMID:
19515182
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk